imipramine has been researched along with alprazolam in 135 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (32.59) | 18.7374 |
1990's | 71 (52.59) | 18.2507 |
2000's | 13 (9.63) | 29.6817 |
2010's | 7 (5.19) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arévalo, W; Gaviria, LF; Leon, A; León, CA | 1 |
McCann, UD; Ricaurte, GA | 1 |
Buller, R; Nutzinger, D; Scheibe, G; Walther, AU | 1 |
Cox, BJ; Endler, NS; Lee, PS; Swinson, RP | 1 |
Cassano, GB; Musetti, L; Toni, C | 1 |
Agras, WS; Ehlers, A; Haddad, JM; Maddock, RJ; Margraf, J; Roth, WT; Taylor, CB | 1 |
Charney, DS; Heninger, GR; Koleszar, AS; Krystal, JH; Nagy, LM; Woods, SW | 1 |
Klerman, GL; Leon, AC; Portera, L; Shear, MK | 2 |
Hoehn-Saric, R; McLeod, DR; Porges, SW; Zimmerli, WD | 1 |
Amering, M; Buller, R; Deltito, JA; Katschnig, H; Klerman, GL; Lavori, PW; Winter, P | 1 |
Greenwald, S; Prusoff, B; Sholomskas, AJ; Weissman, MM | 1 |
Cole, JO; Gerson, B; Mooney, JJ; Pappalardo, KM; Samson, JA; Schatzberg, AF; Schildkraut, JJ; Waternaux, C | 1 |
Argyle, N; Benkert, O; Brandon, S; Buller, R; Lavori, P; Maier, W; Roth, SM | 1 |
Benkert, O; Buller, R; Goldenberg, IM; Lavori, PW; Maier, W | 1 |
Argyle, N; Benkert, O; Brandon, S; Buller, R; Maier, W; Rosenberg, R; Roth, M | 1 |
Andersch, S; Bech, P; Bruun-Hansen, J; Hanson, L; Kullingsjö, H; Lorentzen, K; Mellergård, M; Ottosson, JO; Rasmussen, S; Rosenberg, NK | 1 |
Bech, P; Lorentzen, K; Mellergård, M; Ottosson, JO; Rosenberg, R | 1 |
Beck, P; Mellergård, M; Ottosson, JO; Rosenberg, NK; Rosenberg, R | 1 |
Bech, P; Mellergård, M; Ottosson, JO; Rosenberg, R | 2 |
Bech, P; Mellergård, M; Ottosson, JO; Rosenberg, NK; Rosenberg, R | 1 |
Burrows, GD; Judd, FK; Norman, TR | 1 |
Clark, DB | 1 |
Argyle, N; Solyom, C; Solyom, L | 1 |
Agras, WS; Clark, DB; Ehlers, A; Hayward, C; Margraf, J; Roth, WT; Taylor, CB | 1 |
Agras, WS; Clark, DB; Ehlers, A; Margraf, J; Roth, WT; Sheikh, J; Taylor, CB | 1 |
Argyle, N; Deltito, JA; Klerman, GL | 1 |
Cox, BJ; Endler, NS; Swinson, RP | 1 |
Christie, S; Lydiard, RB; Zealberg, JJ | 1 |
Andrews, G; Christensen, H; Hadzi-Pavlovic, D; Mattick, RP | 1 |
Albus, M; Bech, P; Buller, R; Maier, W; Nutzinger, D; Shera, D | 1 |
Albus, M; Bech, P; Maier, W; Shera, D | 1 |
Sargent, M | 1 |
Agras, WS; Clark, D; Ehlers, A; Hayward, C; King, R; Maddock, R; Margraf, J; Roth, WT; Taylor, CB | 1 |
Mellergård, M; Rosenberg, NK | 1 |
Bernstein, GA; Borchardt, CM; Garfinkel, BD | 1 |
De Souza, EB; Hoehn-Saric, R; McLeod, DR; Oliver, LK; Zimmerli, WD | 1 |
Albus, M; Buller, R; Hippius, H; Lecrubier, Y; Maier, W; Rosenberg, R | 1 |
Jolkkonen, J; Lepola, U; Riekkinen, P; Rimón, R | 1 |
De Souza, EB; Grigoriadis, DE; Pearsall, D | 1 |
Bissette, G; Nemeroff, CB; Owens, MJ | 1 |
Friedman, S; Rosenblum, LA; Sunderland, G | 1 |
Hoehn-Saric, R; McLeod, DR; Zimmerli, WD | 2 |
Ballenger, JC; Carek, DJ; Cornish-McTighe, D; Steele, JJ | 1 |
Decaria, C; Fairbanks, J; Hollander, E; Liebowitz, MR | 1 |
Ciccone, PE | 1 |
Müller, WE; Rick-Brand, S | 1 |
Scrignar, CB | 1 |
Cameron, OG; Curtis, GC; Lee, M; Nesse, RM | 1 |
Mendels, J; Schless, AP | 1 |
Frankenthaler, LM; Kahn, RJ; McNair, DM; Rizley, R | 1 |
Antal, EJ; Ereshefsky, L; Evans, RL; Grimmig, J; Hamann, G; Lobeck, F; Rawls, WN; Smith, RB; Wells, BG | 1 |
Dollfus, S; Petit, M | 1 |
Hata, T; Itoh, E; Kawabata, A; Kita, T; Nishimura, Y | 1 |
Klerman, GL | 1 |
Blackard, WG; Ettigi, PE; Goldberg, SC; Hamer, RM; Schulz, PM | 1 |
Amsterdam, JD; Chung, HR; Csanalosi, IB; Hurowitz, AM; Kaplan, M; London, J; Rickels, K; Wiseman, K | 1 |
Sheehan, DV; Soto, S | 1 |
Giesecke, ME | 1 |
Cohen, BS; Dillon, D; Fyer, AJ; Gorman, JM; Klein, DF; Liebowitz, MR | 1 |
Coleman, J; Jones, KJ; Sheehan, DV; Strom, TB; Surman, OS; Williams, J | 1 |
Aiken, B; Charney, DS; Goodman, WK; Heninger, GR; Kinch, M; Quadrino, LM; Rifkin, B; Woods, SW | 1 |
Biggs, J; Holden, K; Jacobs, M; Overall, JE | 1 |
Donachie, ND; Faillace, LA; Overall, JE | 1 |
Overall, JE; Sheehan, DV | 1 |
Ballenger, JC; Howell, EF; Laraia, MT; Lydiard, RB | 1 |
Fyer, AJ | 1 |
Antal, EJ; Ereshefsky, L; Evans, RL; Grasela, TH; Smith, RB; Wells, BG | 1 |
Rosenbaum, JF; Tesar, GE | 1 |
Goldstein, S | 1 |
Carr, DB; Fishman, SM; Sheehan, DV | 1 |
Hodges, DH; Sethy, VH | 1 |
Assenzo, JR; Shu, VS | 1 |
Aden, GC; Fabre, LF; Feighner, JP; Rickels, K; Smith, WT | 1 |
Chammas, S; Feighner, JP; Frost, NR; Hendrickson, G; Meredith, CH | 1 |
Barnshaw, HD; Jaffe, K; Kennedy, M; Weingourt, R | 1 |
Brogden, RN; Dawson, GW; Jue, SG | 1 |
Lenox, RH; Peyser, JM; Shipley, JE; Weaver, LA; Williams, JM | 1 |
Stickler, GB; Van Winter, JT | 1 |
Cooper, TB; Friedman, MJ; Harris, PQ; Stolk, JM | 1 |
Keller, MB; Leon, AC; Pollack, MH; Rosenbaum, JF; Shear, MK | 1 |
Leon, AC; Marzuk, PM; Portera, L | 1 |
Campbell, M; Cueva, JE | 1 |
Boyer, W | 1 |
Rosenberg, NK; Rosenberg, R | 1 |
Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK | 1 |
Hammerness, PG; Kaspi, SP; Otto, MW; Pollack, MH; Rosenbaum, JF | 1 |
Brandon, S; Briggs, AC; Stretch, DD | 1 |
Coplan, JD; Gorman, JM; Papp, LA; Tiffon, L | 1 |
Abel, EL; Hannigan, JH | 1 |
Rosenberg, R | 1 |
Ayuso, JL; Cassano, GB; Curtis, GC; Massana, J; Perugi, G; Udina, C | 1 |
Clark, DM; Gelder, MG; Salkovskis, P | 1 |
Benkert, O; Cassano, GB; Curtis, G; Deltito, J; Hippius, H; Klerman, G; Maier, W; Petracca, A; Shera, D; Toni, C | 1 |
Goldenberg, I; Klerman, GL; Leon, AC; Portera, L; Rosenbaum, JF; Shear, MK | 1 |
Baker, LA; Deltito, JA; Goldenberg, IM; Keller, MB; Lavori, PW; Leon, A; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, K | 1 |
Lepola, UM; Riekkinen, PJ; Rimón, RH | 1 |
Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S | 2 |
Dawson, R; Lavori, PW; Shera, D | 1 |
Halonen, T; Jolkkonen, J; Lepola, U; Riekkinen, P; Rimón, R | 1 |
Koponen, H; Leinonen, E; Lepola, U | 1 |
Amering, M; Ballenger, JC; Briggs, A; Buller, R; Cassano, G; Garvey, M; Katschnig, H; Klerman, GL; Roth, M; Stolk, JM | 1 |
Pollack, MH; Pollock, RA; Rosenbaum, JF | 1 |
Amering, M; Ballenger, JC; Katschnig, H; Stolk, JM | 1 |
Leon, AC; Olfson, M; Portera, L | 1 |
Matuzas, W; Thompson, PM; Uhlenhuth, EH; Warner, TD | 1 |
Rickels, K; Schweizer, E | 1 |
Sheikh, JI; Swales, PJ | 1 |
al-Hmoud, N | 1 |
Baker, GB; Bateson, AN; Greenshaw, AJ; Tanay, VM | 1 |
Andersch, S; Hetta, J | 1 |
Leon, AC; Matuzas, W; Uhlenhuth, EH | 1 |
Kendler, KS; Latendresse, SJ; Roberson-Nay, R | 1 |
Amaral, VC; Campos, KF; Miguel, TT; Nunes-de-Souza, RL; Rico, JL | 1 |
El Zahaf, NA; Salem Elhwuegi, A | 1 |
13 review(s) available for imipramine and alprazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Validation criteria for panic disorder as a nosological entity.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Rating Scales; Psychotherapy | 1991 |
A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Combined Modality Therapy; Humans; Imipramine; Panic; Phenelzine; Psychotropic Drugs | 1991 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Trials as Topic; Combined Modality Therapy; Fear; Follow-Up Studies; Humans; Imipramine; Meta-Analysis as Topic; Panic; Placebos | 1990 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Behavior Therapy; Humans; Imipramine; Phobic Disorders | 1988 |
Panic disorder in university students: a review.
Topics: Adult; Alprazolam; Fear; Female; Humans; Imipramine; Male; Panic; Phenelzine; Sex Factors; Students; United States; Universities | 1987 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Diazepam; Humans; Imipramine; Kinetics | 1984 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Clonidine; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Fluoxetine; Humans; Imipramine; Lithium; Mutism; Obsessive-Compulsive Disorder; Phenobarbital; Phenytoin; Phobic Disorders; Schizophrenia; Sleep Wake Disorders; Tranquilizing Agents | 1995 |
Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
Topics: Alprazolam; Double-Blind Method; Humans; Imipramine; Panic Disorder; Prospective Studies; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 1995 |
Drug treatment of panic disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Humans; Imipramine; Panic Disorder | 1993 |
Cognitive treatment for panic disorder.
Topics: Alprazolam; Arousal; Clinical Trials as Topic; Cognitive Behavioral Therapy; Humans; Imipramine; Panic Disorder | 1993 |
Clinical issues in the long-term treatment of panic disorder.
Topics: Age Factors; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Humans; Imipramine; Longitudinal Studies; Panic Disorder; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 1996 |
Panic disorder: long-term pharmacotherapy and discontinuation.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Chronic Disease; Controlled Clinical Trials as Topic; Humans; Imipramine; Panic Disorder; Time Factors | 1998 |
69 trial(s) available for imipramine and alprazolam
Article | Year |
---|---|
[Patients with panic disorder: a 5-year follow-up study].
Topics: Adult; Alprazolam; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 1992 |
Pretreatment anxiety level as differential predictor in outpatients with panic disorder.
Topics: Adult; Alprazolam; Anxiety; Female; Humans; Imipramine; Male; Outpatients; Panic Disorder; Prognosis; Psychiatric Status Rating Scales; Treatment Outcome | 1992 |
Treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Double-Blind Method; Female; Humans; Imipramine; Male; Panic Disorder; Psychiatric Status Rating Scales | 1992 |
Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
Topics: Adult; Alprazolam; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Imipramine; Neuropsychological Tests; Panic Disorder; Placebos | 1992 |
Imipramine and alprazolam effects on stress test reactivity in panic disorder.
Topics: Adult; Alprazolam; Anxiety; Arrhythmias, Cardiac; Blood Pressure; Carbon Dioxide; Cold Temperature; Exercise Test; Female; Galvanic Skin Response; Heart Rate; Humans; Imipramine; Lipids; Male; Mental Processes; Panic Disorder; Psychiatric Status Rating Scales; Respiratory Function Tests; Stress, Psychological | 1992 |
Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Single-Blind Method | 1992 |
Assessing impairment in patients with panic disorder: the Sheehan Disability Scale.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Alprazolam; Disability Evaluation; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Personality Assessment; Psychometrics | 1992 |
Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety; Arrhythmia, Sinus; Blood Pressure; Double-Blind Method; Female; Heart; Heart Rate; Humans; Imipramine; Male; Parasympathetic Nervous System; Psychiatric Status Rating Scales; Vagus Nerve | 1992 |
Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study.
Topics: Adult; Alprazolam; Cross-Cultural Comparison; Cross-Sectional Studies; Female; Humans; Imipramine; Incidence; Male; Panic Disorder; Patient Acceptance of Health Care | 1992 |
A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
Topics: Aged; Aged, 80 and over; Alprazolam; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales | 1992 |
Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
Topics: Adult; Agoraphobia; Alprazolam; Arousal; Double-Blind Method; Fear; Female; Humans; Imipramine; Male; Panic; Panic Disorder; Personality Tests; Social Behavior | 1991 |
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
Topics: Adult; Age Factors; Alprazolam; Anxiety Disorders; Arousal; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Panic; Personality Tests; Prognosis | 1991 |
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Panic; Prognosis; Psychiatric Status Rating Scales; Social Environment | 1991 |
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Arousal; Child; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic; Personality Tests; Psychiatric Status Rating Scales; Psychometrics; Scandinavian and Nordic Countries | 1991 |
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Arousal; Humans; Imipramine; Panic; Personality Tests; Psychiatric Status Rating Scales; Psychometrics; Social Environment | 1991 |
Characteristics of panic disorder patients responding to placebo.
Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Male; Panic; Patient Dropouts; Personality Tests; Placebo Effect; Psychiatric Status Rating Scales; Psychometrics; Psychopathology; Scandinavian and Nordic Countries | 1991 |
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Imipramine; Panic; Personality Tests; Psychiatric Status Rating Scales; Psychometrics; Scandinavian and Nordic Countries | 1991 |
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male; Panic; Personality Tests; Psychiatric Status Rating Scales; Psychometrics; Psychopathology; Scandinavian and Nordic Countries; Social Environment | 1991 |
The structure of phobias in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Personality Tests; Phobic Disorders; Psychometrics | 1991 |
Surreptitious drug use by patients in a panic disorder study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Female; Humans; Imipramine; Male; Outcome and Process Assessment, Health Care; Panic; Patient Compliance; Placebos; Self Medication | 1990 |
How "blind" are double-blind studies?
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic; Placebos; Psychotherapy | 1991 |
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male; Outcome and Process Assessment, Health Care; Panic; Placebos | 1991 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Trials as Topic; Combined Modality Therapy; Fear; Follow-Up Studies; Humans; Imipramine; Meta-Analysis as Topic; Panic; Placebos | 1990 |
Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; Personality Assessment; Personality Tests; Psychometrics; Reproducibility of Results | 1990 |
Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; Personality Assessment; Personality Tests | 1990 |
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disability Evaluation; Double-Blind Method; Fear; Female; Hemodynamics; Humans; Imipramine; Male; Panic; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic | 1990 |
Patterns of response during placebo treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Follow-Up Studies; Humans; Imipramine; Multicenter Studies as Topic; Panic; Personality Tests; Placebos | 1990 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Phobic Disorders; Psychiatric Status Rating Scales | 1990 |
Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Double-Blind Method; Female; Humans; Imipramine; Male; Panic; Psychiatric Status Rating Scales | 1990 |
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double-Blind Method; Fear; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Imipramine; Long-Term Care; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Somatostatin | 1989 |
Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
Topics: Adolescent; Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Placebos; Sleep Stages | 1986 |
A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Fear; Humans; Imipramine; Middle Aged; Panic; Phobic Disorders; Psychiatric Status Rating Scales; Random Allocation | 1986 |
Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Topics: Adult; Alprazolam; Analysis of Variance; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Time Factors | 1988 |
Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
Topics: Adult; Alprazolam; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales | 1988 |
Overview of the Cross-National Collaborative Panic Study.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Goals; Humans; Imipramine; Panic; Placebos; Quality Control | 1988 |
Cortisol differentially predicts response to imipramine and alprazolam.
Topics: Adult; Alprazolam; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Hydrocortisone; Imipramine; Male; Random Allocation | 1988 |
Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Topics: Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Diazepam; Double-Blind Method; Female; Humans; Imipramine; Male; Personality Inventory; Placebos; Psychiatric Status Rating Scales | 1987 |
Recent developments in the treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clinical Trials as Topic; Fear; Humans; Imipramine; Lactates; Lactic Acid; Panic; Phenelzine | 1987 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; Humans; Imipramine; Lymphocyte Activation; Middle Aged; Panic; Phenelzine; Phobic Disorders | 1986 |
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Imipramine; Panic; Patient Dropouts; Psychiatric Status Rating Scales; Time Factors; Trazodone | 1986 |
Comparison of alprazolam and imipramine for treatment of outpatient depression.
Topics: Adolescent; Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Middle Aged; Patient Dropouts; Personality Inventory; Psychiatric Status Rating Scales | 1987 |
Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
Topics: Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Manuals as Topic; Patient Compliance; Patient Dropouts; Personality Inventory; Psychiatric Status Rating Scales; Random Allocation | 1987 |
Use of statistics in the analysis of side effect data from clinical trials of psychoactive agents.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Imipramine; Psychotropic Drugs; Statistics as Topic | 1982 |
Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Informed Consent; Male; Middle Aged | 1983 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Diazepam; Humans; Imipramine; Kinetics | 1984 |
Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Imipramine; Male; Middle Aged; Random Allocation | 1984 |
Pattern of placebo response in panic disorder.
Topics: Alprazolam; Follow-Up Studies; Humans; Imipramine; Panic Disorder; Placebo Effect; Time Factors; Treatment Outcome | 1995 |
Three years follow-up of panic disorder patients: a naturalistic study.
Topics: Adult; Alprazolam; Analysis of Variance; Chronic Disease; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Treatment Outcome | 1994 |
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Topics: Adult; Aged; Alprazolam; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Middle Aged; Panic Disorder; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1994 |
Cognitive behavior therapy for treatment-refractory panic disorder.
Topics: Adult; Alprazolam; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Pilot Projects; Psychiatric Status Rating Scales; Psychotherapy, Group; Treatment Outcome | 1994 |
Subtyping of panic disorder by symptom profile.
Topics: Adult; Alprazolam; Colombia; Europe; Female; Humans; Imipramine; Interview, Psychological; Linear Models; Male; Mexico; Middle Aged; Panic Disorder; Respiration Disorders; United States | 1993 |
Maintenance drug therapy of panic disorder.
Topics: Agoraphobia; Alprazolam; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imipramine; Long-Term Care; Panic Disorder; Personality Inventory; Recurrence | 1993 |
Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.
Topics: Adolescent; Adult; Aged; Alprazolam; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic Disorder; Patient Compliance; Psychiatric Status Rating Scales | 1994 |
A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
Topics: Adult; Aged; Alprazolam; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Personality Assessment; Psychometrics | 1993 |
Effect size as a measure of symptom-specific drug change in clinical trials.
Topics: Adult; Alprazolam; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales | 1993 |
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Topics: Adult; Aged; Alprazolam; Arousal; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Personality Assessment | 1993 |
Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Personality Inventory | 1993 |
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Patient Dropouts; Placebos; Prospective Studies; Severity of Illness Index; Treatment Outcome | 1993 |
Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Topics: Adult; Alprazolam; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imipramine; Male; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
A multiple imputation strategy for clinical trials with truncation of patient data.
Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Bayes Theorem; Bias; Data Interpretation, Statistical; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Treatment Outcome | 1995 |
Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
Topics: Adult; Alprazolam; Antidepressive Agents, Tricyclic; Female; GABA Modulators; gamma-Aminobutyric Acid; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Synaptic Transmission | 1995 |
Long-term follow-up after a drug trial for panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Treatment Outcome | 1995 |
Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial.
Topics: Alprazolam; Follow-Up Studies; Humans; Imipramine; Panic Disorder; Prognosis; Prospective Studies; Quality of Life; Time Factors | 1996 |
Service utilization and expenditures for the treatment of panic disorder.
Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Community Mental Health Services; Cross-Cultural Comparison; Direct Service Costs; Drug Therapy, Combination; Female; Health Expenditures; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Patient Care Team; Primary Health Care | 1997 |
Growing placebo response rate: the problem in recent therapeutic trials?
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Double-Blind Method; Humans; Imipramine; Panic Disorder; Placebo Effect; Research Design | 1997 |
Panic disorder: long-term pharmacotherapy and discontinuation.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Chronic Disease; Controlled Clinical Trials as Topic; Humans; Imipramine; Panic Disorder; Time Factors | 1998 |
Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Pilot Projects | 1999 |
A 15-year follow-up study of patients with panic disorder.
Topics: Activities of Daily Living; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male; Panic Disorder; Recurrence; Retreatment; Selective Serotonin Reuptake Inhibitors; Social Adjustment; Social Environment; Treatment Outcome | 2003 |
Psychopathology of panic attacks in panic disorder.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Cognition; Humans; Imipramine; Panic Disorder; Psychotherapy; Recurrence | 2006 |
56 other study(ies) available for imipramine and alprazolam
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; Designer Drugs; Dose-Response Relationship, Drug; Humans; Imipramine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic; Panic Disorder; Recurrence | 1992 |
A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
Topics: Agoraphobia; Alprazolam; Female; Humans; Imipramine; Male; Panic Disorder; Psychiatric Status Rating Scales; Treatment Outcome | 1992 |
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
Topics: Adult; Alprazolam; Bipolar Disorder; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Psychometrics | 1991 |
Follow-up study of patients with panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Behavior Therapy; Combined Modality Therapy; Follow-Up Studies; Humans; Imipramine; Panic Disorder; Psychotropic Drugs | 1991 |
Surreptitious drug use by panic disorder patients.
Topics: Alprazolam; Clinical Trials as Topic; Humans; Imipramine; Panic Disorder; Placebos; Self Medication | 1991 |
Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole.
Topics: Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Female; Humans; Imipramine; Middle Aged; Panic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1991 |
Panic disorder.
Topics: Alprazolam; Behavior Therapy; Fear; Health Education; Humans; Imipramine; National Health Programs; National Institute of Mental Health (U.S.); Organizational Objectives; Panic; Phobic Disorders; United States; United States Substance Abuse and Mental Health Services Administration | 1990 |
Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Electromyography; Epinephrine; Female; Heart Rate; Humans; Imipramine; Male; Middle Aged; Norepinephrine; Personality Tests | 1990 |
Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Brain; Desipramine; Diazepam; Imipramine; Male; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, Corticotropin-Releasing Hormone; Receptors, Neurotransmitter; Receptors, Serotonin | 1989 |
Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Brain; Corticotropin-Releasing Hormone; Imipramine; Male; Rats; Rats, Inbred Strains | 1989 |
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing Behavior; Humans; Imipramine; Lactates; Lactic Acid; Macaca; Macaca radiata; Male; Models, Biological; Panic; Placebos; Sleep; Substance Withdrawal Syndrome | 1989 |
Symptoms and treatment responses of generalized anxiety disorder patients with high versus low levels of cardiovascular complaints.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Heart Diseases; Heart Rate; Humans; Imipramine; Male; Middle Aged; Personality Inventory | 1989 |
Three cases of panic disorder with agoraphobia in children.
Topics: Adolescent; Agoraphobia; Alprazolam; Child; Fear; Female; Humans; Imipramine; Male; Panic; Phobic Disorders | 1989 |
Pharmacological dissection of panic and depersonalization.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imipramine; Manuals as Topic; Panic | 1989 |
Action of imipramine and alprazolam in panic disorder.
Topics: Alprazolam; Anxiety Disorders; Fear; Humans; Imipramine; Panic; Receptors, Adrenergic; Receptors, GABA-A; Sympathetic Nervous System | 1988 |
Direct and indirect effects of alprazolam and imipramine on alpha 1- and alpha 2-adrenoceptors in mouse forebrain.
Topics: Alprazolam; Animals; Binding, Competitive; Brain Chemistry; Clonidine; Imipramine; Male; Mice; Prazosin; Receptors, Adrenergic, alpha | 1988 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desensitization, Psychologic; Escape Reaction; Family; Fear; Female; Humans; Imipramine; Male; Muscle Relaxation; Muscle Spasticity; Panic; Patient Education as Topic; Phenelzine; Phobic Disorders; Physical Exertion; Stress, Psychological | 1986 |
How antipanic drugs might work.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Panic | 1986 |
[Chemotherapy principles of severe somatic expressions of anxiety in adolescents].
Topics: Adolescent; Alprazolam; Anxiety; Female; Humans; Imipramine; Somatoform Disorders | 1988 |
The abnormal open-field behavior of SART-stressed rats and effects of some drugs on it.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Chlorpromazine; Diazepam; Dibenzazepines; Imipramine; Male; Motor Activity; Polysaccharides; Rats; Rats, Inbred Strains; Stress, Physiological | 1988 |
Antipanic drug effects during lactate infusion in lactate-refractory panic patients.
Topics: Adult; Agoraphobia; Alprazolam; Clonidine; Desipramine; Fear; Female; Fluoxetine; Humans; Imipramine; Lactates; Lactic Acid; Male; Panic; Phobic Disorders; Psychological Tests; Psychotropic Drugs | 1987 |
Multivariate analysis of changes in panic frequency counts.
Topics: Alprazolam; Fear; Humans; Imipramine; Panic; Phenelzine; Statistics as Topic | 1986 |
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female; Humans; Imipramine; Male; Panic | 1987 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Anxiety, Separation; Behavior Therapy; Combined Modality Therapy; Humans; Imipramine; Manuals as Topic; Panic; Phenelzine; Phobic Disorders; Psychotherapy | 1987 |
An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interaction.
Topics: Adult; Alprazolam; Drug Interactions; Evaluation Studies as Topic; Humans; Imipramine; Male; Pharmacokinetics; Regression Analysis; Research; Research Design; Software | 1987 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; Desipramine; Fear; Female; Humans; Imipramine; Male; Middle Aged; Panic; Phenelzine; Propranolol; Psychiatric Status Rating Scales | 1986 |
Sequential treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Drug Administration Schedule; Drug Therapy, Combination; Fear; Humans; Imipramine; Panic | 1986 |
Thyroid indices in panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Middle Aged; Panic; Phenelzine; Thyrotropin; Thyroxine; Triiodothyronine | 1985 |
Alprazolam in a biochemical model of depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Depression; Diazepam; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Imipramine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine | 1982 |
A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales | 1983 |
Comparison of alprazolam with imipramine and placebos.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depression; Humans; Imipramine | 1984 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperventilation; Imipramine; Male; Monoamine Oxidase Inhibitors; Panic; Phenelzine; Phobic Disorders; Propranolol; Syndrome | 1984 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorder; Diazepam; Dopamine beta-Hydroxylase; Double-Blind Method; Female; Humans; Imipramine; Longitudinal Studies; Male; Middle Aged | 1984 |
More reliable outcome measures can reduce sample size requirements.
Topics: Alprazolam; Depressive Disorder; Humans; Imipramine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Treatment Outcome | 1995 |
Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
Topics: Adult; Alprazolam; Antidepressive Agents, Tricyclic; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Imipramine; Lorazepam; Male; Panic Disorder; Retrospective Studies; Treatment Outcome | 1994 |
The immobility response in the forced swim test: paradoxical effect of imipramine.
Topics: Alprazolam; Animals; Behavior, Animal; Imipramine; Male; Motor Activity; Propranolol; Rats; Rats, Inbred F344 | 1994 |
A naturalistic 6-year follow-up study of patients with panic disorder.
Topics: Adult; Alcoholism; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Panic Disorder; Personality Inventory; Psychiatric Status Rating Scales; Suicide; Suicide Prevention; Treatment Outcome | 1996 |
Experimental procedures and the placebo response.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Humans; Imipramine; Panic Disorder; Placebo Effect | 1998 |
Koro-like syndrome in a Jordanian male.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Combined Modality Therapy; Humans; Imipramine; Jordan; Koro; Male; Postoperative Complications; Psychotherapy; Spermatic Cord Torsion; Syndrome | 1999 |
Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Brain Stem; Buspirone; Gene Expression Regulation; Imipramine; Infusions, Parenteral; Male; Medulla Oblongata; Phenelzine; Pons; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Time Factors | 2001 |
A latent class approach to the external validation of respiratory and non-respiratory panic subtypes.
Topics: Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Diagnostic and Statistical Manual of Mental Disorders; Epidemiologic Methods; Female; Humans; Imipramine; Male; Panic Disorder; Phenotype; Placebos; Psychiatric Status Rating Scales; Recurrence; Respiration Disorders; Somatoform Disorders; Time Factors; Treatment Outcome | 2012 |
Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Diazepam; Escape Reaction; Factor Analysis, Statistical; Fluoxetine; Food Chain; Imipramine; Male; Mice; Motor Activity; Posture; Predatory Behavior; Rats; Rats, Long-Evans; Time Factors; Yohimbine | 2013 |
The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.
Topics: Alprazolam; Animals; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Hypokinesia; Imipramine; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pyridines; Stress, Psychological; Swimming; Time Factors; Vigabatrin; Zolpidem | 2014 |